Hologic (HOLX) Tops Q2 EPS by 5c; offers guidance

Hologic (NASDAQ: HOLX) reported Q2 EPS of $1.03, $0.05 better than the analyst estimate of $0.98. Revenue for the quarter came in at $0 versus the consensus estimate of $1.02 billion.

GUIDANCE:

Hologic sees FY2024 EPS of $4.02-$4.12, versus the consensus of $4.03. Hologic sees FY2024 revenue of $4-4.05 billion, versus the consensus of $4.03 billion.

Hologic sees Q3 2024 EPS of $0.98-$1.05, versus the consensus of $1.02. Hologic sees Q3 2024 revenue of $992.5-1.0075 billion, versus the consensus of $1.01 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
• PepsiCo (PEP) Tops Q3 EPS by 4c, cuts EPS forecast
• Standard Motor Products CFO to resign, interim replacement named